Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

Share Price is delayed by 15 minutes
Get Live Data
7.40    -0.25 (-3.27%)
Bid:
7.30
Ask:
7.50
Spread: 0.20 (2.74%)
Market Cap: £3.24m
FDBK Live PriceLast checked at - London Stock Exchange

Intraday Feedback Share Chart

Circ re. EGM

28 Feb 2005 17:04

Feedback PLC28 February 2005 FEEDBACK PLC 28 FEBRUARY 2005 Feedback plc Extraordinary general meeting to be convened pursuant to section 142 Companies Act 1985 As the net assets of Feedback plc (the "Company") are presently less than halfof its called up share capital, the Directors are obliged by section 142 of theCompanies Act 1985 to convene an extraordinary general meeting ("EGM") of theCompany for the purpose of considering whether any, and if so what, steps shouldbe taken to deal with this situation. There has been a continuing diminution in the net assets of the Company inrecent years, as evidenced in the annual accounts for the year ended 31 March2004 and the interim results for the six months to 30 September 2004. This has arisen as a result of a combination of factors, including tradinglosses, necessary provisions made in respect of the Company's now closed definedbenefit scheme and a loss on the sale of the Company's former subsidiary,Teknical Limited. In addition, management accounts for the 4 months to January 2005 show thatthere has been a further diminution in assets since 30 September 2004 and afurther additional pension charge. As a result the Company's net assets have fallen to less than half of itscalled-up share capital. The Directors have been concerned about the financial position of the Companyand its subsidiaries (the "Group") and have referred to this, in particular, inthe interim statement to 30 September 2004 and at the annual general meetinglast year. Matters which have received attention are: (1) As announced on 24 February 2005, the Occupational Pensions RegulatoryAuthority has agreed to extend the period in which the shortfall in the pensionfund can be addressed. As a result of this the Company can reduce its annualcontributions to the pension scheme by over £600,000 to £521,400. (2) A loan of US$1,000,000 from Mr T Charlton, a former non-executivedirector, has been renegotiated, deferring repayment until 30 September 2009. (3) A long term solution depends upon a sustainable improvement in the levelof turnover and the associated cost structure. To achieve this, the board ofdirectors has undertaken a reorganisation of the sales function across theGroup, reorganised the internal reporting structure and reduced staff numbers.A review of the Group's property requirements and associated costs is at anadvanced stage, with the aim of providing the most appropriate facilities forthe Group's business whilst reducing costs. The circular convening the EGM to be held on Thursday 24th March 2005 at 11.00a.m. has today been posted to shareholders and copies are available from theCompany's registered office. Enquiries: David Sawyer 01892 653322 Chief Executive Feedback plc Philip Davies Charles Stanley & Co. Limited 020 7953 2457 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Apr 20202:00 pmRNSPrice Monitoring Extension
27th Apr 202011:05 amRNSSecond Price Monitoring Extn
27th Apr 202011:00 amRNSPrice Monitoring Extension
24th Apr 20207:00 amRNSGrant of Options
20th Apr 20207:00 amRNSBleepa rolled out at PAH NHS Trust for Covid-19
26th Mar 20203:52 pmRNSFeedback Medical to offer Bleepa for COVID-19
18th Feb 20207:00 amRNSInterim Results
3rd Feb 202012:21 pmRNSAppointment of Non-Executive Director
21st Jan 202010:30 amRNSChange of Registered Office
13th Jan 20207:00 amRNSLicence agreement with Imaging Engineering
19th Nov 20197:00 amRNSResult of AGM
18th Nov 20197:01 amRNSAGM Statement
18th Nov 20197:00 amRNSFirst Bleepa pilot study initiated with NHS Trust
24th Oct 20198:28 amRNSFinal Results: Revenue up 23%
17th Oct 20197:00 amRNSUpdate re Bleepa®
27th Sep 20192:52 pmRNSStatement re share price
4th Sep 20197:00 amRNSBleepa - the clinical messaging app - at NHS Expo
3rd Sep 20199:46 amRNSHolding(s) in Company
2nd Sep 201912:24 pmRNSHolding(s) in Company
2nd Sep 20197:00 amRNSHolding(s) in Company
30th Aug 20195:00 pmRNSTotal Voting Rights
29th Aug 20192:06 pmRNSResult of General Meeting
29th Aug 20197:00 amRNSBoard Changes
13th Aug 20192:45 pmRNSPosting of Circular and Notice of General Meeting
12th Aug 20197:00 amRNSProposed placing and subscription to raise £2m
7th Aug 201910:47 amRNSStatement re Online Commentary
26th Jul 201912:03 pmRNSBleepa - revolutionising clinical messaging
10th Jul 20197:00 amRNSOutcome of strategic review and trading update
10th Jun 20199:28 amRNSHolding(s) in Company
7th Jun 201910:07 amRNSHolding(s) in Company
25th Apr 20197:00 amRNSTrading update
9th Apr 20197:00 amRNSFeedback Medical CEO appointed Feedback plc CEO
14th Feb 20197:00 amRNSFeedback Medical appoints Dr Tom Oakley as CEO
24th Jan 20197:00 amRNSHalf-year Results
23rd Jan 20192:02 pmRNSResult of AGM
30th Nov 20185:00 pmRNSTotal Voting Rights
29th Nov 20182:37 pmRNSFinal Results
22nd Nov 201812:59 pmRNSFeedback retains industry standard certification
19th Nov 20182:56 pmRNSDirector/PDMR Shareholding
19th Nov 201811:49 amRNSHolding(s) in Company
16th Nov 20189:16 amRNSHolding(s) in Company
15th Nov 201811:35 amRNSResult of General Meeting
1st Nov 20183:11 pmRNSHolding(s) in Company
31st Oct 20185:00 pmRNSTotal Voting Rights
31st Oct 20184:15 pmRNSHolding(s) in Company
29th Oct 20182:44 pmRNSNotice of General Meeting
25th Oct 20187:00 amRNSProposed placing and subscription to raise £1.375m
22nd Oct 20187:00 amRNSExpansion of European customer base
3rd Oct 20187:00 amRNSTrading update
1st Oct 20187:00 amRNSAppointment of Joint Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.